Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Vocal Cord Dysfunction

ClinicalTrials.gov lists 32 trials for Vocal Cord Dysfunction or a narrower condition beneath it. Chinese Academy of Sciences has the most among industry and government lead sponsors, with 1.

MeSH D064706 Respiratory Tract Diseases C08 C09
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 3 Phase 4 Phase 4 2 Not applicable Not applicable 13 Observational Observational 12 Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 3 Phase 4 Phase 4 2 Not applicable Not applicable 13 Observational Observational 12

Trials per phase

18 of the 32 trials are tagged with Vocal Cord Dysfunction itself; the rest are tagged with a narrower condition beneath it.

Get the Vocal Cord Dysfunction report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Vocal Cord Dysfunction trials start? (18)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2002: 1 trials (Not applicable 1) 2008: 1 trials (Phase 4 1) 2009: 2 trials (Observational 1, Phase 3 1) 2010: 1 trials (Phase 3 1) 2011: 1 trials (Not applicable 1) 2012: 2 trials (Not applicable 1, Phase 3 1) 2013: 1 trials (Not applicable 1) 2014: 1 trials (Not applicable 1) 2015: 2 trials (Not applicable 1, Phase 1 1) 2017: 3 trials (Observational 2, Not applicable 1) 2018: 2 trials (Observational 1, Not applicable 1) 2019: 4 trials (Observational 2, Not applicable 2) 2020: 1 trials (Observational 1) 2021: 1 trials (Observational 1) 2022: 2 trials (Observational 2) 2023: 3 trials (Not applicable 2, Phase 4 1) 2024: 2 trials (Observational 1, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 2
2024 2
2023 3
2022 2
2021 1
2020 1
2019 4
2018 2
2017 3
2015 2

No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Vocal Cord Dysfunction trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2 1
Phase 3 3
Phase 4 2
Not applicable 13
Observational 12

How many Vocal Cord Dysfunction trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 3
Completed 20
Terminated 2
Withdrawn 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Vocal Cord Dysfunction trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Chinese Academy of Sciences 1

Which drugs are being tested for Vocal Cord Dysfunction? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Carbon Dioxide 1
Iron 1

Interventions as named in the registry (11)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
L:Lidocaine 2
NaCl 0.9% NS 1
1% Sevoflurane 1
Control (placebo) group 1
Methacholine (MCh) Challenge Testing 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Vocal Cord Dysfunction? (18)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Peripheral airways dysfunction measured by oscillometry differentiates asthma from inducible laryngeal obstruction. Respiratory medicine 2025 Yes
Infections including SARS-CoV-2 as triggers for vocal cord dysfunction. The journal of allergy and clinical immunology. In practice 2024 Yes
Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2022 Yes
Ultrasound prediction for vocal cord dysfunction in patients scheduled for anterior cervical spine surgeries: a prospective cohort study. Journal of clinical monitoring and computing 2021 Yes
Effect of Posterior Tracheopexy on Risk of Recurrence in Children after Recurrent Tracheo-Esophageal Fistula Repair. Journal of the American College of Surgeons 2021 Yes

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages